Skip to content

Optimum dose of electroacupuncture for chronic knee pain: a randomized controlled pilot trial

Optimum dose of electroacupuncture for chronic knee pain: a randomized controlled pilot trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16008580
Enrollment
Unknown
Registered
2016-06-02
Start date
2016-06-05
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic knee pain

Interventions

Treatment group 1:Electroacupuncture (3 times weekly)
Treatment group 2:Electroacupuncture (once weekly)

Sponsors

Heilongjiang Province undergraduate college young innovative talent training plan
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) aged 40 years and more; (2) had a history of knee pain of >3 months duration; (3) knee pain on most days of the past month; (4) an average knee pain severity over the past month of >=4 out of 10 on an 11-point NRS and; (5) morning knee stiffness of <30 minutes duration; (6) no electroacupuncture therapy or other relative treatment has been received within 2 weeks prior to study entry; and (7) an informed consent document has been signed.

Exclusion criteria

Exclusion criteria: (1) pain in the knee caused by inflammatory, malignant, or autoimmune disease; (2) history of knee arthroplasty on the most painful knee; (3) wait-listed for any knee surgery for either knee; (4) history of any knee surgery in previous 6 months; (5) any other condition affecting lower limb function (eg trauma, neurological condition); (6) history of any knee injection in past 4 months (eg cortisone, hyaluronic acid); (7) current use of oral or injectable anticoagulant medication; (8) use of electroacupuncture in past 2 weeks; (9) any bleeding disorder; (10) serious acute or chronic organic disease or mental disorder, pregnancy or breastfeeding; (11) any other medical condition precluding participation in the trial (eg kidney or liver disease, deep vein thrombosis).

Design outcomes

Primary

MeasureTime frame
11-point NRS;

Secondary

MeasureTime frame
Western Ontario and McMaster Universities Arthritis Index (WOMAC);

Countries

China

Contacts

Public ContactZhongren Sun

Heilongjiang University of Chinese Medicine

sunzhongren2011@163.com+86 0451-82193008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026